skip to main content
Global Search Configuration

Companion diagnostics are poised to be a huge growth area worldwide, with a CAGR of 20.1% over the next 5 years, making it a $6B industry by 2022. These often in-vitro medical devices provide essential information for the efficacy of a corresponding drug or biological product, and are also used for pre-determining the efficacy of treatment. Their growth is being propelled in most countries by a number of favorable factors

In this recording we focus on the area of oncology technologies and pathways. We discuss:

  • Examples of how companies used these new technology regulations in applications
  • Biomarker-driven drug development
  • Lessons from orphan drug development
  • New technologies in play such as next-gen sequencing and liquid biopsy
  • The regulatory context for these developments

Will reimbursement prove to be the biggest barrier as three gene therapies gain regulatory approval?


Learn more in the "Trends in Gene Therapy report", available to buy here

Read also


Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: